
TEGTOL CR-200 TAB
Formulation:Carbamazepine 200 mg
Use For: TEGTOL CR-200 Tablet contains Carbamazepine 200 mg, an antiepileptic medication primarily used to manage and control certain types of seizures in patients with epilepsy. It works by reducing abnormal electrical activity in the brain, which helps to prevent seizures. TEGTOL CR-200 is also effective in treating trigeminal neuralgia, a condition characterized by sudden, severe facial nerve pain. Additionally, it may be prescribed for managing bipolar disorder to help stabilize mood and reduce the frequency of mood swings. The tablet is a controlled-release formulation, ensuring a steady level of the drug in the bloodstream for prolonged therapeutic effect. It is usually taken orally with or without food, as directed by a healthcare professional. Patients using TEGTOL CR-200 should undergo regular monitoring due to potential side effects such as dizziness, drowsiness, or blood disorders. This medication should not be stopped suddenly without medical advice, as it may lead to increased seizure frequency or withdrawal symptoms.
TEGTOL CR-200 TAB (Carbamazepine Controlled Release 200 mg)
Product Overview:
TEGTOL CR-200 contains Carbamazepine Controlled Release 200 mg, a well-established anticonvulsant and mood-stabilizing agent used in the management of epilepsy, bipolar disorder, and neuropathic pain. Its controlled-release formulation ensures a gradual and consistent delivery of the active ingredient, maintaining stable blood levels and reducing dosing frequency. This helps improve therapeutic outcomes while minimizing side effects such as drowsiness and dizziness.
Therapeutic Uses:
Epilepsy (partial and generalized tonic-clonic seizures)
Trigeminal neuralgia
Bipolar disorder (acute mania and maintenance)
Neuropathic pain
Glossopharyngeal neuralgia
Alcohol withdrawal syndrome (adjunctive)
Mechanism of Action:
Carbamazepine works by stabilizing the inactivated state of voltage-gated sodium channels in neurons, thereby reducing the ability of the nerve to fire rapidly and excessively. This decreases the propagation of abnormal electrical discharges in the brain and provides mood-stabilizing effects by modulating neurotransmitter activity. The controlled-release formulation allows for prolonged therapeutic action and reduced plasma fluctuations.
Advantages:
Controlled release for sustained drug levels and fewer side effects
Effective for both seizures and mood stabilization
Reduces frequency and severity of epileptic episodes
Proven efficacy in trigeminal neuralgia and other neuropathic pain syndromes
Once or twice-daily dosing for improved patient compliance
Suitable for long-term therapy with proper monitoring
For PCD Pharma Franchise:
Monopoly rights in unrepresented areas
Premium blister or alu-alu packaging
Competitive rates and high margin potential
Promotional inputs (MR bags, LBLs, catch covers, visual aids)
On-time dispatch and round-the-clock customer support
DCGI-approved formulations and documentation assistance
For Third-Party Manufacturing:
WHO-GMP compliant manufacturing facility
Customizable packaging and labeling options
Advanced quality assurance and batch traceability
Scalable production capacity for large-volume orders
Regulatory and documentation support for market authorization
Carbamazepine Controlled Release 200 mg is a prescription drug indicated for the management of seizures, bipolar mood disorders, and neuropathic pain. It is especially beneficial for patients requiring steady plasma drug levels without the peaks and troughs that can result in breakthrough symptoms or increased side effects. The controlled-release technology allows for consistent therapeutic action over time and helps maintain mood balance in patients with bipolar disorder. It also provides significant pain relief in conditions like trigeminal neuralgia.
Uses:
Epilepsy (partial & generalized seizures)
Trigeminal neuralgia
Bipolar affective disorder (mania and maintenance)
Neuropathic pain
Adjunct in alcohol withdrawal
Benefits:
Prolonged therapeutic effect with fewer doses
Reduced CNS-related side effects (sedation, dizziness)
Ideal for chronic use in epilepsy and bipolar disorder
Improved quality of life for neuropathic pain sufferers
Side Effects:
May include dizziness, drowsiness, nausea, vomiting, ataxia, blurred vision, or rash. Rare but serious effects include blood dyscrasias (e.g., aplastic anemia, agranulocytosis), liver dysfunction, or hyponatremia. Regular monitoring of blood counts and liver function is recommended during long-term use.
KEYWORDS
Carbamazepine tablets, Tegtol CR-200, anticonvulsant medicine, epilepsy treatment, trigeminal neuralgia tablets, bipolar disorder medication, neuropathic pain relief, sodium channel blocker, controlled release carbamazepine, epilepsy drugs PCD, carbamazepine PCD pharma, mood stabilizer medicine, neuralgia painkiller, seizure control tablet, pharma franchise for epilepsy, WHO GMP carbamazepine, CR carbamazepine manufacturing, third-party epilepsy medicine, neurology PCD products, CNS drug manufacturers, best carbamazepine brand, affordable seizure medicine, carbamazepine for bipolar, antiepileptic tablet PCD, neuropathic pain pharma franchise, CNS disorder treatment, carbamazepine 200 mg price, tegretol alternative, glossopharyngeal neuralgia drug, neuralgia treatment PCD, CR tablets manufacturers, sustained-release carbamazepine, anticonvulsant bulk supply, Indian pharma franchise, low cost epilepsy meds, pharma franchise for mental health, drug for mood swings, antimanic tablet supply, high-quality CR tablets, epilepsy medicine suppliers, GMP certified manufacturers, pharma distributorship CNS, pain relief for nerve pain, DCGI approved anticonvulsant, epilepsy therapy franchise, epilepsy seizure medicine, CR carbamazepine export, antiepileptic WHO GMP, mental health medicine supplier, mood stabilizing medicine, psychiatric franchise opportunities, epilepsy medicine PCD company, bipolar medicine manufacturers, CNS segment pharma franchise, anticonvulsant third party, seizure disorder drugs, carbamazepine neurology use, CNS PCD products India, drug for epileptic fits, antiepileptic formulations, brain disorder tablet, antiepileptic drug PCD franchise, carbamazepine long acting, CR formulation anticonvulsant, neuro pharma products, carbamazepine CR brands, neuropathy medicine PCD, nerve pain reliever tablet, WHO GMP mood stabilizers, mental wellness medication, epilepsy pharma franchise India, pharma company for neurology, trigeminal pain reliever, chronic nerve pain drug, psychological disorder medicine, drug for seizure episodes, neurology segment franchise, CNS disease management drug, carbamazepine sodium blocker, epilepsy patient treatment, nerve block medicine, psychiatric illness medicine, psychiatric PCD pharma, long acting carbamazepine brand, controlled release CNS drug, CR carbamazepine pharma, best mood stabilizer tablet, antiepileptic medicine supply, psychiatric disorders tablet, pharma company for CR tablets, PCD pharma neurology drugs, CR anticonvulsant tablets, antiepileptic product range, franchise for neurology drugs, CNS drug suppliers India, third-party CNS drugs, neurology care products, tegretol substitute India, nerve disorder medicine, antimanic treatment tablet, pharma marketing carbamazepine, pharma export epilepsy drug, chronic epilepsy control, neuralgia pharma medicine, nerve medication PCD, pain modulator medicine, CR mood stabilizer supply, mental health therapy tablet, epilepsy management drugs, neurological treatment PCD, psychiatric care PCD company, pharma wholesaler CNS drugs, CNS therapy franchise India, anticonvulsant CR formulation, brain disorder control drugs, epileptic attack medicine, psychiatric health franchise, WHO-GMP certified mood stabilizer, CNS disorders pharma solutions, psychiatric care manufacturer, long-term epilepsy treatment, mental health disorder drug, carbamazepine epilepsy control, CNS segment pharma marketing, best CR anticonvulsant, nervous system treatment drug, nerve block pharma franchise, pharma export bipolar drug, neurology pharma CR range, CNS PCD distributors India, epilepsy pharma export India, psychiatric CNS formulation, mood stabilizer pharma exporter, CNS medicine suppliers India, brain disorder pharma PCD, neurology disorder control tablet, WHO GMP CR epilepsy drug, bipolar control tablet India, CNS health pharma supplier,carbamazepine controlled release tablet, carbamazepine 200 CR exporters, epilepsy franchise pharma, seizure disorder pharma franchise, anti-seizure medication third-party, trigeminal neuralgia treatment pharma, carbamazepine pain relief tablet, WHO GMP neuro medicine, CNS care tablets, controlled-release epilepsy drugs, carbamazepine tablet suppliers, carbamazepine manufacturers India, CR antiepileptic supplier, low-dose carbamazepine PCD, pharma for bipolar depression, mental health tablet franchise, neuropathic pain tablet supplier, long-acting epilepsy medicine, Indian neuro pharma companies, neurology franchise opportunity, antiepileptic bulk exporters, CR mood stabilizer brands, antiepileptic drug distributors, neurology treatment tablet, nerve pain tablet manufacturers, psychiatric disorder treatment drug, neurology care third-party manufacturing, Indian epilepsy medicine PCD, mood disorder management pharma, brain stabilizer drug suppliers, pharma for seizure patients, epileptic treatment franchise, psychiatric illness drug supply, bipolar mood stabilizer manufacturer, pharma for trigeminal pain, neurological wellness product range, pharma exporters India carbamazepine, antiepileptic PCD range India, CR tablet formulation suppliers, anticonvulsant generic brand supply, epilepsy drug pharma franchise India, mental health management drug, neurological health PCD pharma, seizure relief third-party manufacturing, neuropathic pain pharma solution, CNS drug franchise opportunities, WHO-GMP certified neuro range, neurology pharma exporters India, psychiatric pharma PCD range, bulk epilepsy drug manufacturer, neurology medicines for franchise, Indian exporter of carbamazepine CR, CNS pharma company India, leading CNS drug manufacturers, antiepileptic WHO GMP approved, nerve stabilizer tablet exporters, CR mood stabilizer brands India, best antiepileptic CR tablets, pharmaceutical epilepsy range, anticonvulsant manufacturers India, pharma distributor CR tablets, seizure management drug PCD, nervous system drug third-party, neuro segment pharmaceutical franchise, CR epilepsy treatment India, epilepsy tablet exporter from India, carbamazepine 200 CR manufacturer, pharma for seizure disorder patients, trigeminal neuralgia pharma franchise, neuropsychiatric drug suppliers, WHO approved epilepsy drugs, GMP certified neuro franchise, brain disorder drug exporters, CNS illness pharma range, mental health drug distributor India, low cost neuro pharma products, epilepsy drugs private labeling, neurology range contract manufacturing, nerve pain drug for third-party, bipolar tablet PCD franchise, epilepsy control drugs India, neurology third-party manufacturer India, seizure medicine franchise business, pharma manufacturing bipolar drug, CNS franchise pharma support, Indian neuropsychiatric drug maker, bulk manufacturing epilepsy tablets, neurology pharma third-party service, WHO GMP mood stabilizer suppliers, nerve pain reliever third-party, seizure control drug PCD pharma, Indian CNS franchise opportunity, pharma company for neurological care, CR epilepsy treatment PCD, neuro pharma contract manufacturing, CNS care drug exporter India, carbamazepine 200 sustained release, brain chemical stabilizer medicine, pharma franchise for epilepsy drugs, neuro range for monopoly franchise, psychiatric tablet WHO GMP, neurological disorder drug franchise, long-release seizure medication, nerve pain management third-party, anti-seizure drugs manufacturers, GMP epilepsy drug suppliers, drug for nerve impulse control, pharma marketing for neurological disease, WHO certified psychiatric tablet, epilepsy CR tablet third-party production, Indian CR antiepileptic supply, seizure prevention pharma franchise, psychiatric segment PCD pharma, third-party for mental health drugs, epilepsy disorder pharma support, Indian exporter CNS tablets, pharma partner for neurology drugs, neuro pharma contract manufacturing India, epilepsy solution tablet WHO GMP, neurological disorder drug suppliers, pharma PCD for brain disorders, mental illness tablet manufacturing, Indian third-party CNS pharma, psychiatric treatment tablet exporters, epilepsy drug contract manufacturer, brain disorder medication India, low price CR carbamazepine tablets, pharmaceutical partners for CNS drugs, WHO compliant CR tablet maker, CR seizure drug PCD pharma, private label neurological drug, psychiatric care medicine producers, pharma for nervous system treatment, Indian WHO GMP antiepileptic suppliers, WHO-GMP epilepsy tablet producer, pharma for neuropathy pain treatment, CR CNS drug range exporters, WHO-GMP compliant neuro medicine, India’s top carbamazepine exporters, CR formulation epilepsy care, neuro disorder pharma range, Indian CNS medicine producers, PCD pharma for mood stabilizers, drug for trigeminal pain franchise, long-acting anticonvulsant exporter, neurological franchise business India, pharma franchise for psychiatric care, CR drug exporters for neurology, pharma for neurological seizures, Indian suppliers of CR anticonvulsants, CNS health drug third-party, epilepsy segment pharma partners, seizure therapy PCD pharma India, mental health segment pharma franchise, top pharma company for epilepsy drugs, CR formulation manufacturers India, pharma marketing for bipolar treatment, CR drug supply for PCD companies, WHO GMP certified seizure medicine, CR carbamazepine drug traders, neuropsychiatric disorder pharma supplier, PCD distributor of mood stabilizers, CNS formulation CR tablets India.